UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Loss of response and frequency of adverse events in patients with ulcerative colitis and Crohn’s disease when switching from the original infliximab to its biosimilars

Terapevtic̆eskii arhiv, 2021-02, Vol.93 (2), p.150-157

2021

Volltextzugriff (PDF)

Pharmacological and clinical feature of rebamipide: new therapeutic targets

Terapevtic̆eskii arhiv, 2020-02, Vol.92 (2), p.104-111

2020

Volltextzugriff (PDF)

Evaluation of efficacy and comparative frequency of adverse events in patients with ulcerative colitis receiving the original infliximab and its biosimilar. One year of observation

Terapevtic̆eskii arhiv, 2019-08, Vol.91 (8), p.41-46

2019

Volltextzugriff (PDF)

Biomarkers of inflammatory bowel disease activity

Terapevtic̆eskii arhiv, 2018-12, Vol.90 (12), p.107-111

2018

Volltextzugriff (PDF)

Adherence to therapy of patients with inflammatory bowel diseases

Terapevtic̆eskii arhiv, 2018-12, Vol.90 (12), p.4-11

2018

Volltextzugriff (PDF)

Stem Cell Therapy for Perianal Crohn's Disease

Terapevtic̆eskii arhiv, 2018-04, Vol.90 (3), p.60-66

2018

Volltextzugriff (PDF)

Personalized medicine in the treatment of inflammatory bowel diseases

Terapevtic̆eskii arhiv, 2018-02, Vol.90 (2), p.4-11

2018

Volltextzugriff (PDF)

Clostridium difficile in inflammatory bowel disease

Terapevticheskii arkhiv, 2018-11, Vol.90 (11), p.32-36

2018

Volltextzugriff (PDF)

Effectiveness of treatment of moderate ulcerative colitis with prolonged mesalazine in real clinical practice

Medicinskij sovet, 2021-10 (15), p.144-151

2021

Volltextzugriff (PDF)

Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice

Terapevtic̆eskii arhiv, 2018-06, Vol.90 (6), p.74-80

2018

Volltextzugriff (PDF)

The use of fecal calprotectin in monitoring activity of inflammatory bowel diseases

Terapevtic̆eskii arhiv, 2019-05, Vol.91 (4), p.53

2019

Volltextzugriff (PDF)

Mesenchymal stromal cells of bone marrow and azathioprine in Crohn's disease therapy

Terapevtic̆eskii arhiv, 2018-02, Vol.90 (2), p.47-52

2018

Volltextzugriff (PDF)

Use of mesenchymal stem cells in the combination therapy of ulcerative colitis

Terapevtic̆eskii arhiv, 2016-01, Vol.88 (2), p.44

2016

Volltextzugriff (PDF)

Evaluation of the efficacy of MMX mesalazine therapy for moderate ulcerative colitis

Medicinskij sovet, 2021-05 (5), p.113-123

2021

Volltextzugriff (PDF)

Systemic manifestations of inflammatory bowel diseases

Terapevtic̆eskii arhiv, 2020-02, Vol.92 (2), p.4-11

2020

Volltextzugriff (PDF)

Comparative evaluation of the effectiveness of monotherapy of ulcerative colitis with mesalazine MMX and combination therapy with non-prolonged mesalazines with rectal forms

Medicinskij sovet, 2022-08 (14), p.96-106

2022

Volltextzugriff (PDF)

Cell Therapy of Refractory Crohn’s Disease

Bulletin of experimental biology and medicine, 2013-11, Vol.156 (1), p.139-145

2013

Volltextzugriff (PDF)

Methodology for building the optimal test bench of software and hardware complexes of control systems

Journal of physics. Conference series, 2020-12, Vol.1694 (1), p.12003

2020

Volltextzugriff (PDF)

System analysis and processing of parameters of the test bench

Journal of physics. Conference series, 2020-12, Vol.1694 (1), p.12002

2020

Volltextzugriff (PDF)

Efficacy of adalimumab for Crohn's disease in real clinical practice

Terapevtic̆eskii arhiv, 2017-01, Vol.89 (2), p.20-27

2017

Volltextzugriff (PDF)

ON INHERENTLY PURE MONOGENIC SEMIGROUPS WITH A CENTRAL IDEMPOTENT

Herald of Omsk University, 2021, Vol.26 (3), p.4-9

Knyazev, O. V.

2021

Volltextzugriff (PDF)

Psoriasis and inflammatory bowel diseases: pathogenetic pathways and the choice of biologic therapy (a literature review)

Alʹmanakh klinicheskoĭ medit͡s︡iny, 2019-12, Vol.47 (6), p.568-578

2019

Volltextzugriff (PDF)

P338 The dependence of the level of Glycoprotein type 2 on the level of Zonulin in Crohn's disease

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i731-i731

2024

Volltextzugriff (PDF)

THE RESULTS OF THE USE OF 5-AMINOSALICYLIC ACID AS AN ANTI-RELAPSE AND MAINTENANCE THERAPY ULCERATIVE COLITIS MODERATE SEVERITY IN CLINICAL PRACTICE

Medical Council, 2018-01 (20), p.108-117

2018

Volltextzugriff (PDF)

Long-term infliximab therapy for ulcerative colitis in real clinical practice

Terapevtic̆eskii arhiv, 2016-01, Vol.88 (8), p.46-52

2016

Volltextzugriff (PDF)

1 – 25 von 911

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(804)
Mit Volltextzugriff
(711)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(313)
Physical Sciences
(207)
Physics
(148)
Technology
(104)
Chemistry
(88)
Life Sciences & Biomedicine
(73)
Physics, Applied
(63)
Materials Science
(61)
Chemistry And Materials Science
(60)
Fruits
(48)
Optics
(43)
Physics And Astronomy
(42)
Materials Science, Multidisciplinary
(39)
Humans
(38)
Chemistry, Physical
(36)
Ulcerative Colitis
(36)
Engineering
(31)
Physics, Condensed Matter
(29)
General & Internal Medicine
(27)
Medicine, General & Internal
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Loss of response and frequency of adverse events in patients with ulcerative colitis and Crohn’s disease when switching from the original infliximab to its biosimilars

Pharmacological and clinical feature of rebamipide: new therapeutic targets

Evaluation of efficacy and comparative frequency of adverse events in patients with ulcerative colitis receiving the original infliximab and its biosimilar. One year of observation

Biomarkers of inflammatory bowel disease activity

Adherence to therapy of patients with inflammatory bowel diseases

Stem Cell Therapy for Perianal Crohn's Disease

Personalized medicine in the treatment of inflammatory bowel diseases

Clostridium difficile in inflammatory bowel disease

Effectiveness of treatment of moderate ulcerative colitis with prolonged mesalazine in real clinical practice

Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice

The use of fecal calprotectin in monitoring activity of inflammatory bowel diseases

Mesenchymal stromal cells of bone marrow and azathioprine in Crohn's disease therapy

Use of mesenchymal stem cells in the combination therapy of ulcerative colitis

Evaluation of the efficacy of MMX mesalazine therapy for moderate ulcerative colitis

Systemic manifestations of inflammatory bowel diseases

Comparative evaluation of the effectiveness of monotherapy of ulcerative colitis with mesalazine MMX and combination therapy with non-prolonged mesalazines with rectal forms

Cell Therapy of Refractory Crohn’s Disease

Methodology for building the optimal test bench of software and hardware complexes of control systems

System analysis and processing of parameters of the test bench

Efficacy of adalimumab for Crohn's disease in real clinical practice

ON INHERENTLY PURE MONOGENIC SEMIGROUPS WITH A CENTRAL IDEMPOTENT

Psoriasis and inflammatory bowel diseases: pathogenetic pathways and the choice of biologic therapy (a literature review)

P338 The dependence of the level of Glycoprotein type 2 on the level of Zonulin in Crohn's disease

THE RESULTS OF THE USE OF 5-AMINOSALICYLIC ACID AS AN ANTI-RELAPSE AND MAINTENANCE THERAPY ULCERATIVE COLITIS MODERATE SEVERITY IN CLINICAL PRACTICE

Long-term infliximab therapy for ulcerative colitis in real clinical practice

Suchergebnisse filtern